1. |
唐露, 司晶, 徐寒梅. 肾纤维化相关信号通路研究进展. 药学进展, 2021, 45(7): 532-538.
|
2. |
陈婷, 黄文辉, 许丽丽, 等. 鸢尾素在急性肾损伤中的研究进展. 华西医学, 2023, 38(1): 116-120.
|
3. |
Do DV, Park SY, Nguyen GT, et al. The effects of irisin on the interaction between hepatic stellate cell and macrophage in liver fibrosis. Endocrinol Metab (Seoul), 2022, 37(4): 620-629.
|
4. |
Liao X, Zhan W, Li R, et al. Irisin ameliorates endoplasmic reticulum stress and liver fibrosis through inhibiting PERK-mediated destabilization of HNRNPA1 in hepatic stellate cells. Biol Chem, 2021, 402(6): 703-715.
|
5. |
Ren Y, Zhang J, Wang M, et al. Identification of irisin as a therapeutic agent that inhibits oxidative stress and fibrosis in a murine model of chronic pancreatitis. Biomed Pharmacother, 2020, 126: 110101.
|
6. |
Peng H, Wang Q, Lou T, et al. Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys. Nat Commun, 2017, 8(1): 1493.
|
7. |
Lund RJ, Davies MR, Hruska KA. Bone morphogenetic protein-7: an anti-fibrotic morphogenetic protein with therapeutic importance in renal disease. Curr Opin Nephrol Hypertens, 2002, 11(1): 31-36.
|
8. |
Lv W, Booz GW, Wang Y, et al. Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol, 2018, 820: 65-76.
|
9. |
Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther, 2023, 8(1): 129.
|
10. |
敬雪明, 张诗琬, 喻雪琴, 等. 信号通路在肾纤维化发生机制中作用的研究进展. 山东医药, 2020, 60(2): 102-105.
|
11. |
Diwan V, Brown L, Gobe GC. Adenine-induced chronic kidney disease in rats. Nephrology (Carlton), 2018, 23(1): 5-11.
|
12. |
Gan W, Chen W, Li T, et al. Circulating irisin level in chronic kidney disease patients: a systematic review and meta-analysis. Int Urol Nephrol, 2022, 54(6): 1295-1302.
|
13. |
赵丽华, 高宇. 鸢尾素在糖脂代谢相关疾病中的研究进展. 中国动脉硬化杂志, 2023, 31(8): 731-736.
|
14. |
Zhang J, Bi J, Ren Y, et al. Involvement of GPX4 in irisin’s protection against ischemia reperfusion-induced acute kidney injury. J Cell Physiol, 2021, 236(2): 931-945.
|
15. |
Jiang S, Oh DS, Dorotea D, et al. Dojuksan ameliorates tubulointerstitial fibrosis through irisin-mediated muscle-kidney crosstalk. Phytomedicine, 2021, 80: 153393.
|
16. |
Kim S, Jeong CH, Song SH, et al. Micellized protein transduction domain-bone morphogenetic protein-7 efficiently blocks renal fibrosis via inhibition of transforming growth factor-beta-mediated epithelial-mesenchymal transition. Front Pharmacol, 2020, 11: 591275.
|
17. |
Li RX, Yiu WH, Tang SC. Role of bone morphogenetic protein-7 in renal fibrosis. Front Physiol, 2015, 6: 114.
|
18. |
Peng W, Zhou X, Xu T, et al. BMP-7 ameliorates partial epithelial-mesenchymal transition by restoring SnoN protein level via Smad1/5 pathway in diabetic kidney disease. Cell Death Dis, 2022, 13(3): 254.
|
19. |
Ruiqi L, Ming P, Qihang S, et al. Saikosaponin D inhibits peritoneal fibrosis in rats with renal failure by regulation of TGFβ1/BMP7/Gremlin1/Smad pathway. Front Pharmacol, 2021, 12: 628671.
|
20. |
Manson SR, Song JB, Hruska KA, et al. HDAC dependent transcriptional repression of Bmp-7 potentiates TGF-β mediated renal fibrosis in obstructive uropathy. J Urol, 2014, 191(1): 242-252.
|